drug combination

407 articles

Research
October 22, 2021 • 6 Min

Triple Immunotherapy Shows Dramatic Results

Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.

Research
July 31, 2020 • 3 Min

Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer

This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.

Treatments
December 27, 2019 • 5 Min

Chemotherapy: A Key Player in the Battle Against Pancreatic Cancer

Dr. Gabriela Chiorean walks us through the different types of chemotherapy treatments for pancreatic cancer and how they work. Join Let’s Win PC in our fight.

Research
December 21, 2022 • 2 Min

Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer

Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.

Research
November 21, 2016 • 4 Min

Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients

Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.

Research
October 9, 2017 • 1 Min

Investigating a Drug Used for Other Cancers

In a clinical trial, researchers are adding the drug decitabine to gemcitabine, for patients with advanced cancer that is not responding to treatment.

Survivor Stories
November 20, 2019 • 6 Min

Tumor RNA Testing Leads to Treatment with a New Drug

When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.

Research
March 29, 2019 • 2 Min

Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer

Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.

Research
November 1, 2018 • 5 Min

PARP Inhibitors for Pancreatic Cancer Maintenance Treatment

Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.

Research
September 14, 2016 • 2 Min

Slowing the Growth of Pancreatic Tumors Before Surgery

A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.

Research
June 3, 2016 • 2 Min

Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs

A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.

Research
March 31, 2017 • 4 Min

Clinical Trial of Immunotherapy Plus Sunshine Vitamin May Help in Pancreatic Cancer Fight

Can vitamin D make it easier for chemotherapy drugs to reach the pancreatic cancer tumor? A clinical trial is testing this idea.

Research
October 17, 2019 • 3 Min

Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer

Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.

Research
November 15, 2017 • 2 Min

Trying Targeted Treatments Used for Other Cancers

Researchers are trying kinase inhibitors that are effective for breast cancer, colorectal cancer, and melanoma on pancreatic cancer.

Disease Management
October 28, 2022 • 4 Min

Compassionate Use: An Option Beyond Standard of Care

Investigational drugs can be accessed through the FDA’s compassionate use program. Learn more about how this can be used in pancreatic cancer treatments.